# A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction

> **NCT02980068** · PHASE1 · COMPLETED · sponsor: **Gladwin, Mark, MD** · enrollment: 77 (actual)

## Conditions studied

- Pulmonary; Hypertension
- Heart Failure
- Preserved Ejection Fraction

## Interventions

- **DRUG:** 15N Nitrate
- **DRUG:** 14N Nitrate

## Key facts

- **NCT ID:** NCT02980068
- **Lead sponsor:** Gladwin, Mark, MD
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-28
- **Primary completion:** 2022-02-25
- **Final completion:** 2022-02-25
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02980068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02980068, "A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02980068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*